• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2,2'-联吡啶在大鼠中产生的肢体异常。

Limb anomalies produced by 2,2'-dipyridyl in rats.

作者信息

Oohira A, Nogami H

出版信息

Teratology. 1978 Aug;18(1):63-70. doi: 10.1002/tera.1420180110.

DOI:10.1002/tera.1420180110
PMID:694779
Abstract

The teratogenicity of 2,2'-dipyridyl (DIP), a chelator for ferrous iron, was investigated by administration of single dose of 60 or 75 mg/kg intraperitoneally to pregnant SD rats on days 11.5-14.5. Fetuses examined on day 21 were decreased in weight, and had defects chiefly in the limb. The type and incidence of limb defects differed according to day of treatment. Digital malformations in the forelimb and long-bone defects in the hindlimb were produced with high incidence by treatment on day 12.5, and the frequency of digital malformations in the hindlimb was increased by treatment on day 13.5. Light and electron microscopic examinations revealed the delay of mesenchymal condensation and destruction of mesenchymal cells in the forelimb bud in the early stage after day 12.5 treatment. The normal increase of DNA, protein, collagen and glycosaminoglycan contents in the forelimb bud was markedly inhibited by the treatment. The incorporation activities for [14C]proline and [14C]glucosamine of the forelimb bud were reduced to 50-60% of the control. These results indicate that DIP has potent teratogenic and cytotoxic effects on the development of the rat limb bud.

摘要

通过在妊娠第11.5至14.5天对妊娠SD大鼠腹腔注射60或75mg/kg的单剂量,研究了亚铁螯合剂2,2'-联吡啶(DIP)的致畸性。在第21天检查的胎儿体重减轻,主要肢体存在缺陷。肢体缺陷的类型和发生率因治疗天数而异。在第12.5天治疗可导致前肢指畸形和后肢长骨缺陷的高发生率,在第13.5天治疗会增加后肢指畸形的频率。光镜和电镜检查显示,在第12.5天治疗后的早期,前肢芽中的间充质凝聚延迟和间充质细胞破坏。该治疗显著抑制了前肢芽中DNA、蛋白质、胶原蛋白和糖胺聚糖含量的正常增加。前肢芽对[14C]脯氨酸和[14C]氨基葡萄糖的掺入活性降低至对照的50-60%。这些结果表明,DIP对大鼠肢体芽的发育具有强大的致畸和细胞毒性作用。

相似文献

1
Limb anomalies produced by 2,2'-dipyridyl in rats.2,2'-联吡啶在大鼠中产生的肢体异常。
Teratology. 1978 Aug;18(1):63-70. doi: 10.1002/tera.1420180110.
2
Enhanced expression of limb malformations and axial skeleton alterations in legless mutants by transplacental exposure to retinoic acid.通过经胎盘暴露于视黄酸,无腿突变体中肢体畸形和轴向骨骼改变的表达增强。
Dev Biol. 1994 Jul;164(1):277-89. doi: 10.1006/dbio.1994.1198.
3
Teratogenic effects of nitrazepam in rats.硝西泮对大鼠的致畸作用。
Res Commun Chem Pathol Pharmacol. 1990 Jul;69(1):59-70.
4
Serine-enhanced restoration of 2-methoxyethanol-induced dysmorphogenesis in the rat embryo and near-term fetus.丝氨酸增强2-甲氧基乙醇诱导的大鼠胚胎和近足月胎儿畸形发生的恢复。
Toxicol Appl Pharmacol. 1997 Aug;145(2):415-24. doi: 10.1006/taap.1997.8202.
5
Limb development in mouse embryos. II. Reduction defects, cytotoxicity and inhibition of DNA synthesis produced by cytosine arabinoside.小鼠胚胎的肢体发育。II. 阿糖胞苷产生的肢体发育不全缺陷、细胞毒性及对DNA合成的抑制作用
Teratology. 1978 Aug;18(1):71-92. doi: 10.1002/tera.1420180111.
6
Cytotoxic effects of ethylene glycol monomethyl ether in the forelimb bud of the mouse embryo.
Teratology. 1987 Aug;36(1):23-34. doi: 10.1002/tera.1420360105.
7
Processes involved in retinoic acid production of small embryonic palatal shelves and limb defects.小胚胎腭突和肢体缺陷的视黄酸产生所涉及的过程。
Teratology. 1990 Mar;41(3):299-310. doi: 10.1002/tera.1420410307.
8
Teratogenesis of retinoic acid in rats: susceptible stages and suppression of retinoic acid-induced limb malformations by cycloheximide.维甲酸对大鼠的致畸作用:敏感阶段及环己酰亚胺对维甲酸诱导的肢体畸形的抑制作用
Teratology. 1981 Feb;23(1):25-31. doi: 10.1002/tera.1420230106.
9
Comparative ultrastructural alterations in rabbit limb-buds after a teratogenic dose of either hydroxyurea or methotrexate.致畸剂量的羟基脲或甲氨蝶呤作用后兔肢芽的超微结构比较改变
Teratology. 1981 Apr;23(2):197-215. doi: 10.1002/tera.1420230205.
10
Teratogenic effects of vigabatrin in TO mouse fetuses.氨己烯酸对TO小鼠胎儿的致畸作用。
Teratology. 1997 Mar;55(3):165-76. doi: 10.1002/(SICI)1096-9926(199703)55:3<165::AID-TERA1>3.0.CO;2-1.

引用本文的文献

1
Thalidomide in human immunodeficiency virus (HIV) patients. A review of safety considerations.沙利度胺用于人类免疫缺陷病毒(HIV)患者。安全性考量综述。
Drug Saf. 1992 Mar-Apr;7(2):116-34. doi: 10.2165/00002018-199207020-00004.